rs2518261

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_021956.5(GRIK2):​c.116-88047T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.569 in 151,794 control chromosomes in the GnomAD database, including 24,814 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 24814 hom., cov: 33)

Consequence

GRIK2
NM_021956.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.109

Publications

2 publications found
Variant links:
Genes affected
GRIK2 (HGNC:4580): (glutamate ionotropic receptor kainate type subunit 2) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. The subunit encoded by this gene is subject to RNA editing at multiple sites within the first and second transmembrane domains, which is thought to alter the structure and function of the receptor complex. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. Mutations in this gene have been associated with autosomal recessive cognitive disability. [provided by RefSeq, Jul 2008]
GRIK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • intellectual disability, autosomal recessive 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • neurodevelopmental disorder with impaired language and ataxia and with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.585 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021956.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIK2
NM_021956.5
MANE Select
c.116-88047T>C
intron
N/ANP_068775.1
GRIK2
NM_001166247.1
c.116-88047T>C
intron
N/ANP_001159719.1
GRIK2
NM_175768.3
c.116-88047T>C
intron
N/ANP_786944.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIK2
ENST00000369134.9
TSL:5 MANE Select
c.116-88047T>C
intron
N/AENSP00000358130.6
GRIK2
ENST00000421544.6
TSL:1
c.116-88047T>C
intron
N/AENSP00000397026.1
GRIK2
ENST00000369138.5
TSL:1
c.116-88047T>C
intron
N/AENSP00000358134.1

Frequencies

GnomAD3 genomes
AF:
0.569
AC:
86332
AN:
151676
Hom.:
24786
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.592
Gnomad AMI
AF:
0.477
Gnomad AMR
AF:
0.525
Gnomad ASJ
AF:
0.628
Gnomad EAS
AF:
0.565
Gnomad SAS
AF:
0.423
Gnomad FIN
AF:
0.529
Gnomad MID
AF:
0.586
Gnomad NFE
AF:
0.580
Gnomad OTH
AF:
0.572
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.569
AC:
86414
AN:
151794
Hom.:
24814
Cov.:
33
AF XY:
0.563
AC XY:
41760
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.592
AC:
24496
AN:
41406
American (AMR)
AF:
0.526
AC:
8000
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.628
AC:
2181
AN:
3472
East Asian (EAS)
AF:
0.565
AC:
2905
AN:
5138
South Asian (SAS)
AF:
0.424
AC:
2050
AN:
4830
European-Finnish (FIN)
AF:
0.529
AC:
5593
AN:
10564
Middle Eastern (MID)
AF:
0.579
AC:
169
AN:
292
European-Non Finnish (NFE)
AF:
0.580
AC:
39376
AN:
67854
Other (OTH)
AF:
0.574
AC:
1209
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1931
3862
5794
7725
9656
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.579
Hom.:
11192
Bravo
AF:
0.572
Asia WGS
AF:
0.508
AC:
1771
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.2
DANN
Benign
0.53
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2518261; hg19: chr6-101981778; API